AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (December 6, 2007). doi:10.1152/ajpgi.00237.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/G489    most recent
00237.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Annaba, F.
Right arrow Articles by Alrefai, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annaba, F.
Right arrow Articles by Alrefai, W. A.
Submitted on May 24, 2007
Accepted on November 30, 2007

Modulation of Ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: Association with lipid rafts

Fadi Annaba1, Zaheer Sarwar2, Pradeep Kumar2, Seema Saksena3, Jerrold R. Turner4, Pradeep K. Dudeja5, Ravinder K. Gill2, and Waddah A. Alrefai6*

1 Medicine, University of Illinois at Chicago, Chicago, Illinois, United States
2 University of Illinois at Chicago, United States
3 University of Illinois, United States; University of Illinois
4 Department of Pathology, The University of Chicago, Chicago, Illinois, United States
5 Jesse Brown VA Medical Center, United States; University of Illinois at Chicago, United States
6 University of Illinois at Chicago, United States; University of Illinois at Chicago

* To whom correspondence should be addressed. E-mail: walrefai{at}uic.edu.

Apical Sodium-Dependent Bile Acid Transporter (ASBT) represents a highly efficient conservation mechanism of bile acids via mediating their active transport across the luminal membrane of terminal ileum. To gain insights into the cellular regulation of ASBT, we investigated the association of ASBT with cholesterol and sphingolipid enriched specialized plasma membrane microdomains known as lipid rafts and examined the role of membrane cholesterol in maintaining ASBT function. Human embryonic kidney cells stably transfected with hASBT, human ileal brush border membrane vesicles and human intestinal epithelial Caco-2 cells were utilized for these studies. Floatation experiments on Optiprep density gradient demonstrated the association of ASBT protein with lipid rafts. Disruption of lipid rafts by depletion of membrane cholesterol with methyl-{beta}-cyclodextrin (M{beta}CD) significantly reduced the association of ASBT with lipid rafts which was paralleled by a decrease in ASBT activity in Caco2 and HEK 293 cells treated with M{beta}CD. The inhibition in ASBT activity by M{beta}CD was blocked in the cells treated with M{beta}CD-cholesterol complexes. Kinetic analysis revealed that M{beta}CD treatment decreased the Vmax of the transporter that was not associated with alteration in the plasma membrane expression of ASBT. Our studies illustrate that cholesterol content of lipid rafts is essential for the optimal activity of ASBT and support the association of ASBT with lipid rafts. These findings suggest a novel mechanism by which ASBT activity may be rapidly modulated by alterations in cholesterol content of plasma membrane and thus have important implications in processes related to maintenance of bile acid and cholesterol homeostasis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.